KROS
Keros Therapeutics Inc
NASDAQ: KROS · HEALTHCARE · BIOTECHNOLOGY
$11.12
+0.18% today
Updated 2026-04-30
Market cap
$228.75M
P/E ratio
5.03
P/S ratio
0.94x
EPS (TTM)
$2.30
Dividend yield
—
52W range
$10 – $23
Volume
0.4M
Keros Therapeutics Inc (KROS) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.00M | $10.00M | $2.50M | $20.10M | $20.00M | $151000.00 | $3.55M | $244.06M |
| Revenue growth (YoY) | — | +0.0% | -75.0% | +704.0% | -0.5% | -99.2% | +2251.0% | +6775.0% |
| Cost of revenue | $10.11M | $17.35M | $605000.00 | $898000.00 | $1.61M | $815000.00 | $1.23M | $1.51M |
| Gross profit | $-111000.00 | $-7.35M | $-605000.00 | $20.10M | $-1.61M | $151000.00 | $3.55M | $242.55M |
| Gross margin | -1.1% | -73.5% | -24.2% | 100.0% | -8.1% | 100.0% | 100.0% | 99.4% |
| R&D | $10.11M | $17.38M | $33.86M | $55.14M | $87.27M | $135.26M | $173.63M | $129.64M |
| SG&A | $1.58M | $3.18M | $12.80M | $21.33M | $27.52M | $34.83M | $40.75M | $46.85M |
| Operating income | $-1.69M | $-10.56M | $-46.66M | $-56.37M | $-114.79M | $-169.94M | $-210.83M | $70.62M |
| Operating margin | -16.9% | -105.6% | -1866.3% | -280.5% | -573.9% | -112543.7% | -5939.0% | 28.9% |
| EBITDA | $-774000.00 | $-11.89M | $-44.92M | $-56.35M | $-104.00M | $-152.18M | $-185.82M | $72.13M |
| EBITDA margin | -7.7% | -118.9% | -1796.9% | -280.4% | -520.0% | -100779.5% | -5234.5% | 29.6% |
| EBIT | $-1.08M | $-12.33M | $-45.53M | $-56.73M | $-104.68M | $-152.99M | $-187.05M | $70.62M |
| Interest expense | $6000.00 | $8000.00 | $6000.00 | $4000.00 | $1000.00 | $0.00 | $0.00 | — |
| Income tax | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-1.33M | $-12.34M | $-45.36M | $-58.74M | $-104.68M | $-152.99M | $-187.35M | $87.01M |
| Net income growth (YoY) | — | -824.6% | -267.5% | -29.5% | -78.2% | -46.2% | -22.5% | +146.4% |
| Profit margin | -13.4% | -123.4% | -1814.4% | -292.3% | -523.4% | -101319.2% | -5277.5% | 35.7% |